• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

LncRNA LINC00261 与上皮性卵巢癌患者的化疗耐药及临床预后相关。

LncRNA LINC00261 associates with chemoresistance and clinical prognosis in patients with epithelial ovarian cancer.

机构信息

Department of Obstetrics and Gynecology, Fourth Hospital, Hebei Medical University, Shijiazhuang, China.

Department of Obstetrics and Gynecology, Hebei General Hospital, Shijiazhuang, China.

出版信息

J Obstet Gynaecol Res. 2024 Dec;50(12):2271-2279. doi: 10.1111/jog.16077. Epub 2024 Oct 10.

DOI:10.1111/jog.16077
PMID:39390648
Abstract

OBJECTIVE

The purpose of this experiment is to explore the role of long intergenic noncoding RNA 261 (LINC00261) gene in the chemoresistance and clinical prognosis of epithelial ovarian cancer (EOC).

METHODS

We used matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometry to detect the methylation levels of the LINC00261 promoter region in EOC patient specimens. The expression levels of LINC00261, miR-545-3p, and MT1M in EOC patients were evaluated by quantitative real-time reverse transcriptase PCR (RT-qPCR). Spearman's correlation analysis was used for relevance analyses and clinical prognosis was counted by Kaplan-Meier analysis. Stable overexpressed LINC00261 SKOV3 cells were established to test the influence of LINC00261 on proliferation, platinum sensitivity, migration, and invasion.

RESULTS

The promoter region methylation level of the LINC00261 was hypermethylated and LINC00261 was significantly downregulated in platinum-resistant EOC tissues. The methylation level of LINC00261was significantly negative correlated with its RNA expression in EOC. Moreover, hypermethylation and lower expression of LINC00261 in EOC patients were related to shorter progression-free survival (PFS) and overall survival (OS). Furthermore, Spearman's correlation analysis showed that the expression of miR-545-3p had a negative relevance with LINC00261. According to the website prediction, MT1M might be the downstream target gene of LINC00261. Expression of MT1M was negatively correlated with miR-545-3p and positively with LINC00261 in EOC tissues. And lower MT1M mRNA expression was correlated with chemotherapy resistance and worse prognosis. In vitro, overexpression of LINC00261 could inhibit cisplatin resistance, proliferation, and suppression of migration and invasion in SKOV3 cells.

CONCLUSIONS

This research indicates that the aberrant hypermethylation and low expression of LINC00261 were associated with platinum resistance and adverse outcomes in EOC patients.

摘要

目的

本实验旨在探讨长链非编码 RNA 261(LINC00261)基因在卵巢上皮性癌(EOC)化疗耐药及临床预后中的作用。

方法

采用基质辅助激光解吸电离飞行时间质谱(MALDI-TOF)检测 EOC 患者标本中 LINC00261 启动子区甲基化水平,实时荧光定量逆转录 PCR(RT-qPCR)检测 EOC 患者 LINC00261、miR-545-3p、MT1M 的表达水平。采用 Spearman 相关分析进行相关性分析,采用 Kaplan-Meier 法进行临床预后分析。构建稳定过表达 LINC00261 的 SKOV3 细胞株,检测 LINC00261 对 SKOV3 细胞增殖、铂类药物敏感性、迁移及侵袭的影响。

结果

LINC00261 启动子区呈高甲基化状态,其在铂耐药 EOC 组织中表达明显下调。LINC00261 在 EOC 中的甲基化水平与其 RNA 表达呈显著负相关。此外,EOC 患者 LINC00261 高甲基化及低表达与无进展生存期(PFS)及总生存期(OS)缩短相关。Spearman 相关分析显示,miR-545-3p 的表达与 LINC00261 呈负相关。根据网站预测,MT1M 可能是 LINC00261 的下游靶基因。在 EOC 组织中,MT1M 的表达与 miR-545-3p 呈负相关,与 LINC00261 呈正相关。并且,MT1M mRNA 表达降低与化疗耐药及预后不良相关。体外实验结果表明,过表达 LINC00261 可抑制 SKOV3 细胞的顺铂耐药性、增殖能力,以及对迁移和侵袭的抑制作用。

结论

本研究表明,LINC00261 的异常高甲基化和低表达与 EOC 患者铂类耐药和不良预后相关。

相似文献

1
LncRNA LINC00261 associates with chemoresistance and clinical prognosis in patients with epithelial ovarian cancer.LncRNA LINC00261 与上皮性卵巢癌患者的化疗耐药及临床预后相关。
J Obstet Gynaecol Res. 2024 Dec;50(12):2271-2279. doi: 10.1111/jog.16077. Epub 2024 Oct 10.
2
Hypermethylation of mismatch repair gene hMSH2 associates with platinum-resistant disease in epithelial ovarian cancer.错配修复基因 hMSH2 的高甲基化与上皮性卵巢癌铂耐药疾病相关。
Clin Epigenetics. 2019 Oct 30;11(1):153. doi: 10.1186/s13148-019-0748-4.
3
[Clinical and bioinformatics analysis of the relationship between LAMA3 DNA methylation expression and platinum resistance and prognosis in epithelial ovarian cancer].[LAMA3 DNA甲基化表达与上皮性卵巢癌铂耐药及预后关系的临床与生物信息学分析]
Zhonghua Fu Chan Ke Za Zhi. 2024 Jun 25;59(6):454-464. doi: 10.3760/cma.j.cn112141-20240201-00069.
4
The downregulation of miR-509-3p expression by collagen type XI alpha 1-regulated hypermethylation facilitates cancer progression and chemoresistance via the DNA methyltransferase 1/Small ubiquitin-like modifier-3 axis in ovarian cancer cells.胶原 XI 型α 1 调控的 hypermethylation 下调 miR-509-3p 的表达,通过 DNA 甲基转移酶 1/小泛素样修饰物 3 轴促进卵巢癌细胞的癌症进展和化疗耐药性。
J Ovarian Res. 2023 Jun 29;16(1):124. doi: 10.1186/s13048-023-01191-5.
5
Upregulation of lncRNA AB073614 functions as a predictor of epithelial ovarian cancer prognosis and promotes tumor growth in vitro and in vivo.lncRNA AB073614 的上调可作为上皮性卵巢癌预后的预测因子,并在体外和体内促进肿瘤生长。
Cancer Biomark. 2019;24(4):421-428. doi: 10.3233/CBM-182160.
6
FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.在非浆液性上皮性卵巢癌患者中,FOXM1表达与化疗耐药及不良预后显著相关。
J Exp Clin Cancer Res. 2017 May 8;36(1):63. doi: 10.1186/s13046-017-0536-y.
7
miR-874-3p mitigates cisplatin resistance through modulating NF-κB/inhibitor of apoptosis protein signaling pathway in epithelial ovarian cancer cells.miR-874-3p 通过调节上皮性卵巢癌细胞中 NF-κB/凋亡抑制蛋白信号通路来减轻顺铂耐药性。
Mol Cell Biochem. 2022 Jan;477(1):307-317. doi: 10.1007/s11010-021-04271-6. Epub 2021 Oct 30.
8
The up-regulation of PAK2 indicates unfavorable prognosis in patients with serous epithelial ovarian cancer and contributes to paclitaxel resistance in ovarian cancer cells.PAK2 的上调表明浆液性上皮性卵巢癌患者预后不良,并导致卵巢癌细胞对紫杉醇耐药。
BMC Cancer. 2024 Sep 30;24(1):1213. doi: 10.1186/s12885-024-12969-1.
9
[Bioinformatics analysis of drug-resistant ceRNA in epithelial ovarian cancer].上皮性卵巢癌耐药性竞争性内源RNA的生物信息学分析
Zhonghua Fu Chan Ke Za Zhi. 2021 Feb 25;56(2):121-130. doi: 10.3760/cma.j.cn112141-20200718-00587.
10
Downregulation of lncRNA ASMTL-AS1 in Epithelial Ovarian Cancer Correlates with Worse Prognosis and Cancer Progression.lncRNA ASMTL-AS1 在卵巢上皮性癌中的下调与更差的预后和癌症进展相关。
Horm Metab Res. 2022 Jul;54(7):481-488. doi: 10.1055/a-1872-0546. Epub 2022 Jul 14.

引用本文的文献

1
Increasing linc00261 expression may predict well cancer prognosis, based on the meta-analysis.基于荟萃分析,增加linc00261的表达可能预示着良好的癌症预后。
Discov Oncol. 2025 Jul 1;16(1):1205. doi: 10.1007/s12672-025-02908-2.
2
Unraveling the oncogenic role of LINC00504 and its interaction with miR-545-3p and ARIHI in hepatocellular carcinoma: novel insights for molecular therapy.揭示LINC00504在肝细胞癌中的致癌作用及其与miR-545-3p和ARIHI的相互作用:分子治疗的新见解
Discov Oncol. 2025 Apr 17;16(1):548. doi: 10.1007/s12672-025-02328-2.
3
Clinical Significance of in the Pathogenesis of Pancreatic, Colorectal, Hepatocellular, and Gallbladder Cancer.
[具体内容]在胰腺癌、结直肠癌、肝细胞癌和胆囊癌发病机制中的临床意义
Diseases. 2025 Mar 20;13(3):89. doi: 10.3390/diseases13030089.